In the last five years, Brentwood, Tenn.-based Surgery Partners has shifted from a broad acquisition-heavy growth model toward a more disciplined, high-acuity-first strategy. Like many ASC groups, the company is concentrating on orthopedics, cardiology, and de novo centers and using health system JVs as a growth vehicle. The rejection of Bain’s buyout in 2025 crystallized its bet on remaining a publicly traded, physician-partnered platform. Here’s a breakdown of Surgery Partners growth strategy since 2021.
Read the full article: Inside Surgery Partners’ 5-Year Strategy Pivot //
Source: https://www.beckersasc.com/asc-transactions-and-valuation-issues/inside-surgery-partners-5-year-strategy-pivot/